Home/Filings/4/0001225208-25-002707
4//SEC Filing

SAHNI PAYAL 4

Accession 0001225208-25-002707

CIK 0000078003other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 5:38 PM ET

Size

10.8 KB

Accession

0001225208-25-002707

Insider Transaction Report

Form 4
Period: 2025-02-27
SAHNI PAYAL
Executive Vice President
Transactions
  • Exercise/Conversion

    Stock Appreciation Rights

    2025-02-2719,0540 total
    Exercise: $31.31From: 2025-02-27Exp: 2025-02-27Common Stock (19,054 underlying)
  • Tax Payment

    Common Stock

    2025-02-27$26.06/sh17,846$465,06725,928 total
  • Exercise/Conversion

    Common Stock

    2025-02-27$31.31/sh+19,054$596,58144,242 total
  • Tax Payment

    Common Stock

    2025-02-27$26.10/sh468$12,21543,774 total
Holdings
  • Common Stock

    (indirect: By Rule 16b-3 Plan)
    12,938
Footnotes (4)
  • [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
  • [F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1
  • filerCIK 0001817124

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:38 PM ET
Size
10.8 KB